-原料藥及中間體、活性小分子及定制合成
電話:020-39119399
E-mail:isunpharm@hotmail.com
-原料藥及中間體、活性小分子及定制合成
| 圖示 | 商品編號 | 商品名稱 | 商品簡介 | 操作 |
|---|---|---|---|---|
 |
Sorafenib Tosylate(對甲苯磺酸索拉非尼) is the tosylate salt of sorafenib, a synthetic compound targeting growth signaling and angiogenesis. | 查看 | ||
 |
Trametinib(曲美替尼) is an orally bioavailable inhibitor of mitogen-activated protein kinase kinase (MEK MAPK/ERK kinase) with potential antineoplastic activity. | 查看 | ||
 |
Sorafenib（索拉非尼） is a synthetic compound targeting growth signaling and angiogenesis. | 查看 | ||
 |
SCH772984 is a novel, specific inhibitor of ERK1/2 with IC50 values of 4 nM and 1 nM in cell-free assay, respectively, And show robust efficacy in RAS- or BRAF-mutant cancer cells. | 查看 | ||
 |
SB203580 is a p38 MAPK inhibitor. | 查看 | ||
 |
Vemurafenib(維羅菲尼) is an orally bioavailable, ATP-competitive, small-molecule inhibitor of BRAF(V600E) kinase with potential antineoplastic activity. | 查看 |
